WisdomTree BioRevolution Fund Rating $17.07 +0.16 (+0.95%) (As of 07/26/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings WisdomTree BioRevolution Fund Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.WDNA Aggregate RatingModerate Buy2.70Holdings in WDNA have an aggregate rating of Moderate Buy based on 622 analyst ratings issued in the past year covering 47 companies (68.6% of the portfolio).WDNA Aggregate Price Target$21.1623.96% UpsideHigh Prediction$27.77Average Prediction$21.16Low Prediction$14.91Holdings in WDNA have an aggregate price target of $21.16 and a range of $14.91 to $27.77 covering 47 companies (68.6% of the portfolio).WDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy29 Moderate Buy rating(s)Hold11 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by WisdomTree BioRevolution Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 47 WDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.07%TWSTTwist Bioscience$58.08+1.0%3.2201 of 5 stars3.22 / 5 stars3.00$49.75 -14.3%8Upcoming EarningsInsider Selling2.85%BPMCBlueprint Medicines$112.19-1.3%0.598 of 5 stars0.60 / 5 stars2.63$116.33 3.7%16Upcoming EarningsShort Interest ↑Analyst RevisionNews Coverage2.61%GERNGeron$4.66+8.6%4.3574 of 5 stars4.36 / 5 stars2.86$6.93 48.7%7Analyst ForecastNews Coverage2.52%LLYEli Lilly and Company$805.12-2.0%4.6392 of 5 stars4.64 / 5 stars2.84$858.72 6.7%19Analyst Forecast2.45%NTRANatera$102.67+0.5%1.3314 of 5 stars1.33 / 5 stars3.00$101.19 -1.4%16Upcoming EarningsInsider SellingNews Coverage2.34%AGIOAgios Pharmaceuticals$48.05-0.9%1.3062 of 5 stars1.31 / 5 stars2.50$50.67 5.4%4Upcoming EarningsAnalyst RevisionNews Coverage2.03%VCELVericel$52.32+1.2%1.1858 of 5 stars1.19 / 5 stars3.00$51.33 -1.9%7Upcoming EarningsAnalyst UpgradeShort Interest ↓1.83%SRPTSarepta Therapeutics$144.24-2.2%4.9099 of 5 stars4.91 / 5 stars2.78$187.72 30.1%18Short Interest ↓1.66%BBIOBridgeBio Pharma$27.05+1.3%4.418 of 5 stars4.42 / 5 stars3.00$48.73 80.1%11Upcoming EarningsShort Interest ↑Gap Up1.64%IOVAIovance Biotherapeutics$9.25-1.9%3.7328 of 5 stars3.73 / 5 stars3.00$24.45 164.4%10Gap Up1.59%VRTXVertex Pharmaceuticals$495.26+0.6%3.9637 of 5 stars3.96 / 5 stars2.54$460.30 -7.1%26Upcoming EarningsAnalyst ForecastInsider SellingNews Coverage1.51%REGNRegeneron Pharmaceuticals$1,078.63+1.4%4.2399 of 5 stars4.24 / 5 stars2.78$1,074.95 -0.3%23Upcoming EarningsAnalyst ForecastAnalyst Revision1.50%FATEFate Therapeutics$5.44+0.7%3.6615 of 5 stars3.66 / 5 stars2.21$6.75 24.1%14News CoverageGap Up1.50%ALNYAlnylam Pharmaceuticals$234.84-1.3%3.3781 of 5 stars3.38 / 5 stars2.67$256.73 9.3%24Upcoming EarningsShort Interest ↑1.46%UTHRUnited Therapeutics$338.22+0.5%4.6416 of 5 stars4.64 / 5 stars2.83$330.64 -2.2%12Upcoming EarningsAnalyst ForecastInsider SellingAnalyst RevisionNews Coverage1.44%AMGNAmgen$334.85+0.2%4.4956 of 5 stars4.50 / 5 stars2.52$312.63 -6.6%21Short Interest ↑Analyst Revision1.42%MYGNMyriad Genetics$27.65-0.7%3.6665 of 5 stars3.67 / 5 stars2.40$25.33 -8.4%10Upcoming EarningsShort Interest ↓1.39%IONSIonis Pharmaceuticals$51.45-0.8%3.8922 of 5 stars3.89 / 5 stars2.79$60.18 17.0%19Upcoming EarningsAnalyst ForecastAnalyst Revision1.37%CRSPCRISPR Therapeutics$57.92+0.6%2.054 of 5 stars2.05 / 5 stars2.33$75.71 30.7%18Positive News1.34%CTLTCatalent$58.68+0.4%1.9664 of 5 stars1.97 / 5 stars2.18$55.65 -5.2%11Analyst ForecastShort Interest ↑1.31%DHRDanaher$274.13+1.5%4.7182 of 5 stars4.72 / 5 stars2.71$276.88 1.0%17Earnings ReportAnalyst ForecastInsider SellingShort Interest ↓Analyst RevisionNews Coverage1.29%RAREUltragenyx Pharmaceutical$44.86-0.4%4.3738 of 5 stars4.37 / 5 stars2.93$86.50 92.8%14Upcoming EarningsAnalyst Forecast1.28%DDDuPont de Nemours$80.18+1.5%4.9408 of 5 stars4.94 / 5 stars2.58$91.00 13.5%12Upcoming EarningsShort Interest ↓1.26%STOKStoke Therapeutics$15.86+8.9%3.5012 of 5 stars3.50 / 5 stars2.88$20.57 29.7%8News CoverageGap Up1.26%MRKMerck & Co., Inc.$125.30-0.4%4.4616 of 5 stars4.46 / 5 stars2.75$135.36 8.0%12Upcoming EarningsDividend Announcement1.21%FOLDAmicus Therapeutics$10.18-0.8%4.1696 of 5 stars4.17 / 5 stars2.88$17.57 72.6%8News CoveragePositive News1.19%VCYTVeracyte$23.72-0.2%3.2886 of 5 stars3.29 / 5 stars2.60$27.50 15.9%5Gap Up1.18%AZNAstraZeneca$78.13-0.5%3.4851 of 5 stars3.49 / 5 stars2.90$88.00 12.6%10Short Interest ↓Analyst RevisionNews Coverage1.16%BEAMBeam Therapeutics$33.14+3.0%1.9182 of 5 stars1.92 / 5 stars2.43$43.50 31.3%14Analyst ForecastNews Coverage1.16%ZTSZoetis$179.84-0.5%4.6117 of 5 stars4.61 / 5 stars3.00$212.67 18.3%8Analyst ForecastShort Interest ↓1.12%DOWDOW$52.86+0.0%4.4956 of 5 stars4.50 / 5 stars2.31$59.70 12.9%13Earnings ReportAnalyst ForecastNews Coverage1.12%TSNTyson Foods$61.01+1.2%3.9708 of 5 stars3.97 / 5 stars2.11$60.00 -1.7%9News Coverage1.10%TMOThermo Fisher Scientific$607.14+2.1%4.8507 of 5 stars4.85 / 5 stars2.72$618.94 1.9%18Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.09%DARDarling Ingredients$38.88-1.8%4.6519 of 5 stars4.65 / 5 stars2.82$67.36 73.3%11Earnings ReportAnalyst ForecastNews Coverage1.09%GMABGenmab A/S$28.38+0.9%3.9531 of 5 stars3.95 / 5 stars2.42$49.50 74.4%12Upcoming Earnings1.08%NEONeoGenomics$14.88-1.3%3.7401 of 5 stars3.74 / 5 stars2.90$19.78 32.9%10Upcoming EarningsNews CoverageGap Up1.08%AAgilent Technologies$137.31+1.7%4.6006 of 5 stars4.60 / 5 stars2.50$138.06 0.5%16Short Interest ↓News Coverage1.07%ARWRArrowhead Pharmaceuticals$28.19-2.6%4.174 of 5 stars4.17 / 5 stars2.63$43.25 53.4%8Analyst ForecastAnalyst RevisionNews Coverage1.06%JNJJohnson & Johnson$160.68+0.7%4.7743 of 5 stars4.77 / 5 stars2.43$173.00 7.7%14Analyst DowngradeShort Interest ↓1.06%QGENQiagen$43.92+4.0%4.3411 of 5 stars4.34 / 5 stars2.67$51.05 16.2%9Upcoming EarningsPositive News1.03%LHLaboratory Co. of America$210.90+0.6%4.6842 of 5 stars4.68 / 5 stars2.79$241.29 14.4%14Upcoming EarningsDividend AnnouncementNews Coverage1.03%ARCTArcturus Therapeutics$24.07+4.7%2.318 of 5 stars2.32 / 5 stars3.00$67.60 180.8%6Short Interest ↑1.01%TECHBio-Techne$80.60+2.5%4.586 of 5 stars4.59 / 5 stars2.73$81.00 0.5%11Short Interest ↓1.00%CTVACorteva$55.39+0.2%4.7268 of 5 stars4.73 / 5 stars2.67$63.00 13.7%21Upcoming EarningsNews Coverage0.95%GILDGilead Sciences$77.01+0.7%4.793 of 5 stars4.79 / 5 stars2.33$81.81 6.2%18Options VolumeAnalyst Revision0.94%EDITEditas Medicine$5.65+1.4%4.7695 of 5 stars4.77 / 5 stars2.40$12.90 128.3%10Short Interest ↓Gap Up0.94%BMRNBioMarin Pharmaceutical$84.59-1.2%4.8983 of 5 stars4.90 / 5 stars2.55$102.00 20.6%20Analyst ForecastShort Interest ↓Analyst RevisionNews Coverage This page (BATS:WDNA) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WisdomTree BioRevolution Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share WisdomTree BioRevolution Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
